Michael Jelínek

505 total citations
11 papers, 397 citations indexed

About

Michael Jelínek is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Michael Jelínek has authored 11 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 2 papers in Surgery. Recurrent topics in Michael Jelínek's work include Cell death mechanisms and regulation (2 papers), Cancer-related Molecular Pathways (2 papers) and PARP inhibition in cancer therapy (2 papers). Michael Jelínek is often cited by papers focused on Cell death mechanisms and regulation (2 papers), Cancer-related Molecular Pathways (2 papers) and PARP inhibition in cancer therapy (2 papers). Michael Jelínek collaborates with scholars based in Czechia, United States and Norway. Michael Jelínek's co-authors include Jan Kovář, Lenka Libusová, Jan Brábek, Vladimı́r Čermák, Daniel Rösel, Kamila Balušíková, Jan Šrámek, Vlasta Němcová‐Fürstová, Petr Halada and Iwao Ojima and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Michael Jelínek

11 papers receiving 395 citations

Peers

Michael Jelínek

ONCOL

Natalia Sevillano United States

Karin Bartel Germany

Sajid Rashid Pakistan

Yukitoshi Nagahara Japan

Peifu Feng China

David Foley United Kingdom

Jean‐Philippe Annereau France

Lei Fang China

Xuechi Lin China

Mahendra Seervi India

Natalia Sevillano United States

Michael Jelínek

293 ×1.5

64 ×0.7

ONCOL

52 ×0.6

72 ×1.1

36 ×0.9

Citations per year, relative to Michael Jelínek Michael Jelínek (= 1×) peers Natalia Sevillano

Countries citing papers authored by Michael Jelínek

Since Specialization

Citations

This map shows the geographic impact of Michael Jelínek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Jelínek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Jelínek more than expected).

Fields of papers citing papers by Michael Jelínek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Jelínek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Jelínek. The network helps show where Michael Jelínek may publish in the future.

Co-authorship network of co-authors of Michael Jelínek

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Jelínek. A scholar is included among the top collaborators of Michael Jelínek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Jelínek. Michael Jelínek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Balušíková, Kamila, Radka Václavíková, Michael Jelínek, et al.. (2023). ABCB1 Amplicon Contains Cyclic AMP Response Element-Driven TRIP6 Gene in Taxane-Resistant MCF-7 Breast Cancer Sublines. Genes. 14(2). 296–296. 1 indexed citations

Holý, Petr, Marie Ehrlichová, Changwei Wang, et al.. (2021). The Role of TRIP6, ABCC3 and CPS1 Expression in Resistance of Ovarian Cancer to Taxanes. International Journal of Molecular Sciences. 23(1). 73–73. 13 indexed citations

Pavlíková, Nela, Jan Šrámek, Michael Jelínek, Petr Halada, & Jan Kovář. (2020). Markers of acute toxicity of DDT exposure in pancreatic beta-cells determined by a proteomic approach. PLoS ONE. 15(10). e0229430–e0229430. 8 indexed citations

Čermák, Vladimı́r, Michael Jelínek, Lenka Libusová, et al.. (2020). Microtubule-targeting agents and their impact on cancer treatment. European Journal of Cell Biology. 99(4). 151075–151075. 185 indexed citations

Pavlíková, Nela, Jan Šrámek, Michael Jelínek, et al.. (2019). Upregulation of vitamin D-binding protein is associated with changes in insulin production in pancreatic beta-cells exposed to p,p′-DDT and p,p′-DDE. Scientific Reports. 9(1). 18026–18026. 70 indexed citations

Halada, Petr, et al.. (2019). Differentially Expressed Mitochondrial Proteins in Human MCF7 Breast Cancer Cells Resistant to Paclitaxel. International Journal of Molecular Sciences. 20(12). 2986–2986. 13 indexed citations

Jelínek, Michael, Kamila Balušíková, Vlasta Němcová‐Fürstová, et al.. (2018). Substituents at the C3′ and C3′N positions are critical for taxanes to overcome acquired resistance of cancer cells to paclitaxel. Toxicology and Applied Pharmacology. 347. 79–91. 11 indexed citations

Jelínek, Michael, et al.. (2017). Differing Mechanisms of Death Induction by Fluorinated Taxane SB-T-12854 in Breast Cancer Cells. Anticancer Research. 37(4). 1581–1590. 3 indexed citations

Šrámek, Jan, Vlasta Němcová‐Fürstová, Kamila Balušíková, et al.. (2016). p38 MAPK Is Activated but Does Not Play a Key Role during Apoptosis Induction by Saturated Fatty Acid in Human Pancreatic β-Cells. International Journal of Molecular Sciences. 17(2). 159–159. 13 indexed citations

10.

Jelínek, Michael, Kamila Balušíková, Vlasta Němcová‐Fürstová, et al.. (2015). The role of individual caspases in cell death induction by taxanes in breast cancer cells. Cancer Cell International. 15(1). 8–8. 53 indexed citations

11.

Jelínek, Michael, Kamila Balušíková, Vlasta Němcová‐Fürstová, et al.. (2013). Caspase-2 is involved in cell death induction by taxanes in breast cancer cells. Cancer Cell International. 13(1). 42–42. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact